Alnylam Pharmaceuticals Inc at Sanford C Bernstein Strategic Decisions Conference (Virtual) Transcript
Hi, everybody, and thank you for joining us today. Our first meeting today of this morning is with John Maraganore, the CEO of Alnylam, and I hope I'm not destroying his name too much. RNAi technology has been one of our topics of interest for a really long time. One of those areas where the science and companies actually is ahead of the science in the academia. And John and his team have been one of the leading organizations in this deal. So John, thank you very much for taking the time and joining us today.
Thank you, Ronny. It's great to be here.
Questions & Answers
And John, why won't you take a few minutes and introduce Alnylam to those of us who have not been as exposed to the name before?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
